Sponsors (2)
The bill broadens and strengthens federal vaccine injury compensation (larger awards, expanded eligibility, clearer procedures) and clarifies tax coverage for new preventive products, but does so at the cost of higher expected program and compliance expenses, potential increased per‑dose costs for patients, preserved liability limits, and some legal/administrative uncertainty.
People injured by COVID‑19 and other covered vaccines (including those previously limited to CICP) can seek compensation through the National Vaccine Injury Compensation Program and the Vaccine Injury Compensation Program, expanding access to federal injury remedies.
Vaccine injury claimants can receive larger awards and more time to file—higher death and pain-and-suffering caps and an extended statute of limitations—meaning greater potential financial relief for survivors and injured people.
Program capacity and process clarity are improved: more special masters, clearer filing rules, set regulatory deadlines, delayed tax effective date for administrative transition, and multi-year budget transparency should speed and stabilize adjudication and administration.
Taxpayers and purchasers face larger program costs because higher awards, expanded eligibility, and planned resource needs increase expected payouts and administrative spending.
The added excise tax coverage is likely to be passed through to patients, insurers, and program budgets, increasing per‑dose costs and potentially raising out‑of‑pocket costs or insurance premiums.
The bill preserves and clarifies broad liability protections and limits on civil suits (including barring certain time‑barred or finalized actions), reducing avenues for litigation and potentially limiting private accountability for injuries.
Based on analysis of 6 sections of legislative text.
Modernizes the Vaccine Injury Compensation Program, adds COVID‑19 and other vaccines to VICP coverage, raises some damage caps and filing windows, and expands and alters the federal per‑dose vaccine excise tax.
Official title: To amend the Public Health Service Act to make updates to the Vaccine Injury Compensation Program, and for other purposes.
Introduced July 14, 2026 by Lloyd Alton Doggett · Last progress July 14, 2026
Makes multiple changes to the federal vaccine injury and countermeasures compensation systems and to federal vaccine excise taxes. It raises program decision‑maker staffing and pay/reappointment rules, increases certain damage caps and filing deadlines, requires HHS to add COVID‑19 vaccines to the Vaccine Injury Table, and directs multi‑year budget estimates for program backlogs. It also expands which vaccines are subject to the existing per‑dose excise tax and changes the per‑dose tax rate with a delayed effective date.